Health News
About half the US population are in the priority group for H1N1 virus vaccine, including pregnant women and health workers.
Some cancer screening may do more harm than good
BC's Mark Herzlich tackles cancer treatment head-on
Leading Australian bone and geriatric specialists have hailed the Nepean Consensus Statement meeting on the treatment of osteoporosis in the aged care setting a major success, and a significant step forward in addressing this growing national issue. Osteoporotic fractures are an important cause of morbidity and mortality in residential aged care facilities.
New US legislation granting the Food and Drug Administration (FDA) jurisdiction over tobacco products represents a serious compromise on the part of tobacco control advocates, argues a new essay in this week's open access journal PLoS Medicine.
Three studies published on bmj.com examine the merits of conservative versus aggressive treatment policies of women with low-grade abnormal results detected by cervical screening. Together they form the Trial of Management of Borderline and Other Low-grade Abnormal Smears (TOMBOLA).
Christmas in July cheers Krum cancer patient
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) approved Sculptra(R)Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the appropriate injection technique in healthy patients. Sculptra(R)Aesthetic works gradually to offer natural-looking results that can last up to two years.
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, announced positive top-line efficacy results from the first of two patient cohorts in its second pivotal Phase 3 trial of the investigational compound, Ophena(TM) (ospemifene tablets), for the treatment of postmenopausal vulvovaginal atrophy (VVA). The Company has also successfully completed two long term safety extension studies from its first pivotal Phase 3 studies.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced new six month safety and efficacy results from its fourth Phase II clinical trial using its proprietary, orally-active non-peptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
New research released by the Royal Pharmaceutical Society of Great Britain (RPSGB) reveals how older people are taking a cocktail of medicine without fully understanding what they are or the side effects they are causing. The RPSGB survey shows that nearly half (43%) of over 65's are currently taking over five medicines at any one time. However, one in five admits to not always taking the medicine as prescribed.
Trusted health care sources and continuity of care may help reduce the risk of prostate cancer deaths in African-American men, according to a study published in the current issue of the journal Cancer. James Mohler, MD, Chair of the Department of Urology at Roswell Park Cancer Institute (RPCI), and William R. Carpenter, PhD, Department of Health Policy and Management at the University of North Carolina, are lead investigators.
Local San Diego entrepreneur, Diego Villamizar, working to educate youth on the dangers of skin cancer -- the fastest growing cancer in the U.S. -- and helping promote clean green energy. SKYShades specializes in the design, engineering and installation of cutting-edge, high-quality tension membrane shade fabric structures. The company utilizes special fabrics that block 85-97% of ultraviolet (UV) A&B sun rays. SKYShades also offers exclusive SOLAR ROOFING FABRICS through it's Integrated Building Organic Photovoltaic (OPV) Systems. (PRWeb Jul 29, 2009) Read the full story
The Senate Judiciary Committee's approval on Tuesday of Supreme Court nominee Sonia Sotomayor "cleared the way" for a vote next week in the full Senate, where she is expected to be confirmed, the New York Times reports.
A US study published online ahead of print in a leading medical journal suggests that complications from H1N1 swine flu could hit pregnant women harder, and that pregnant women infected with the virus are hospitalized at four times the rate of infected people in the general population.
Servier Laboratories Limited has been granted permission by the Court of Appeal to challenge a High Court decision made at a Judicial Review in February this year, in which Servier was previously successful in its claim that the National Institute for Health and Clinical Excellence (NICE) had unlawfully failed to provide the economic model underlying its Guidance for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Simi Valley Radiation Oncology Center, a member of the Coastal Radiation Oncology Medical Group, has completed installation of a Varian 6EX Linear Accelerator with IMRT and IGRT, providing patients in the greater Simi Valley area with broader access to advanced cancer treatment technology and increased convenience. (PRWeb Jul 29, 2009) Read the full story at http://www.prweb.com/releases/2009/07/prweb2683144.htm
Joseph W. Belluck of Belluck & Fox, LLP says government should err on side of caution (PRWeb Jul 30, 2009) Read the full story at http://www.prweb.com/releases/2009/07/prweb2687154.htm
Potential late-stage ovarian cancer therapy; currently none available; Diphtheria-encoding genes delivered to tumor site by nanoparticles; Laboratory research; possible human trials about 18 months away (PRWeb Jul 30, 2009) Read the full story at http://www.prweb.com/releases/nanotechnology/ovariancancer/prweb2695794.htm